Yeah, never did get those extra NGIO dividends. His

New Post Public Reply Private Reply Replies (2) Message Board
tc2000chartreader All Aboard #20915
435
Yeah, never did get those extra NGIO dividends. His ‘explanation’ was the difference between a public company like GNBT, and non public like ngio. So between the record date and pay date, the public traded company carries the due bill process and the non public does not. I would be fine with that had not every single PR by the company leading up to the pay date stating the same 2 for 5 dividend. It was only after the fact that they said NGIO was different since it was non public company.

“ FINRA has determined that the original August 30 record date is too long ago to adequately track all the pay due bills from stock being bought and sold by investors, so a new record date of February 17th, 2020 has been established. This will insure everyone who has bought stock since August and retains the stock will receive the dividend not by way of a Pay Due Bill, but rather, directly from Generex. Those who sold stock after the original record date need not worry about anything as they were formally entitled to receive the dividend, but they would have had to transfer the dividend to the buyer of their shares. With the new February 17th record date being established, those who are entitled to receive the 5/2 stock dividend in Generex and the 5/2 stock dividend in NuGenerex Immuno-Oncology will receive it directly from the company.
th
In addition, the pay date is now February 24th and ex-date is February 25 . If a
shareholder sells the stock after the record date the pay due bill process will be in full effect and the shareholder will be required to transfer the dividend stock to the buyer. The ex-date rule in this situation is found in FINRA Rules Section 11140 (b)(2), which reads as follows: “(2) In respect to cash dividends or distributions, stock dividends and/or splits, and the distribution of warrants, which are 25% or greater of the value of the subject security, the ex-dividend date shall be the first business day following the payable date.””

Then he tried to tell me it was the same with the prior NGIO dividend. When you have a non public company, the record date is the date you use since it is not traded so there would be no trading between the record and pay dates. I did not purchase GNBT during the record and pay dates to know if those that did got NGIO. I thought I read that they did, however I have no proof.

That being said, I believe now that we may not be entitled to those NGIO shares. Not because of the dates but rather because the dividend was less than 25% of the company each time. Only on special dividends of 25% or more do you have the due bill process. So the 2 ngio for 5 GNBT since only amounted to less than 5-6% of NGIO being distributed. GNBT holds more than 90% of NGIO. So the reason given was not correct, in my opinion, however the end result may be correct since it was less than 25%.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 2

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 0

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 0

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 5

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 1

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Stock Upgrades: Wall Street Analysts Share Insights

Updated Category News Views 167

Recent Stock Upgrades by Analysts In a recent analysis, top Wall Street analysts have made notable upgrades on several key stocks. Their assessments reflect changes in market dynamics and investor sentiment towards these companies. Below are four significant stock upgrades that are generating buzz among investors. Advanced Micro Devices (NASDAQ: AMD) Jefferies analyst...

Continue Reading
Hamamatsu Photonics and Sirona Dx Form Strategic Alliance

Updated Category News Views 252

Hamamatsu Photonics Partners with Sirona Dx to Advance Technology Access Hamamatsu Photonics, a renowned leader in whole slide imaging and spatial proteomics solutions, has initiated a strategic alliance with Sirona Dx (SDX). This exciting collaboration aims to optimize the technology evaluation process, providing researchers with needed access to in-depth spatial biology...

Continue Reading
Air Quality Monitoring Market Set to Surge by 2031

Updated Category News Views 9

Air Quality Systems Poised for Robust Growth Here's a curveball for those who thought air was just, well, air. Turns out, the market for air quality monitoring systems is rocketing like nobody's business. From 2026 to 2031, it's gonna balloon from a solid $9.61 billion to an impressive $13.86 billion. That's a cool compound annual growth rate of 7.4%. Guess we're finally...

Continue Reading
BARK Inc. Reveals Strong Q3 2025 Earnings Report

Updated Category News Views 396

BARK Inc. Reports Preliminary Third Quarter Results BARK, Inc. (NYSE: BARK), a global leader in omnichannel dog products, has released its preliminary financial results for the third quarter of the fiscal year. The announcement sheds light on the company's performance and growth strategies as it looks towards future developments. Impressive Financial Highlights The...

Continue Reading
Sana Biotechnology's Upcoming Investor Conference Appearances

Updated Category News Views 324

Exciting News from Sana Biotechnology Sana Biotechnology, Inc. (NASDAQ: SANA), a leading company in the field of engineered cell therapies, has recently announced its plans to showcase its innovations and strategies at two renowned investor conferences this December. The company aims to provide significant insights into its business operations and the impact of its...

Continue Reading